Shadlen MF - Search Results

1

Alzheimer's disease symptom severity in blacks and whites.

Shadlen MF, Larson EB, Gibbons L, McCormick WC, Teri L. Shadlen MF, et al. J Am Geriatr Soc. 1999 Apr;47(4):482-6. doi: 10.1111/j.1532-5415.1999.tb07244.x. J Am Geriatr Soc. 1999. PMID: 10203126

2

Research agenda for understanding Alzheimer disease in diverse populations: work group on cultural diversity, Alzheimer's association.

Shadlen MF, McCormick WC, Larson EB. Shadlen MF, et al. Alzheimer Dis Assoc Disord. 2002;16 Suppl 2:S96-S100. doi: 10.1097/00002093-200200002-00012. Alzheimer Dis Assoc Disord. 2002. PMID: 12351923 Review.

3

Survival after initial diagnosis of Alzheimer disease.

Larson EB, Shadlen MF, Wang L, McCormick WC, Bowen JD, Teri L, Kukull WA. Larson EB, et al. Among authors: shadlen mf. Ann Intern Med. 2004 Apr 6;140(7):501-9. doi: 10.7326/0003-4819-140-7-200404060-00008. Ann Intern Med. 2004. PMID: 15068977

4

Ethnicity and cognitive performance among older African Americans, Japanese Americans, and Caucasians: the role of education.

Shadlen MF, Larson EB, Gibbons LE, Rice MM, McCormick WC, Bowen J, McCurry SM, Graves AB. Shadlen MF, et al. J Am Geriatr Soc. 2001 Oct;49(10):1371-8. doi: 10.1046/j.1532-5415.2001.49269.x. J Am Geriatr Soc. 2001. PMID: 11890499

5

Education modifies the effect of apolipoprotein epsilon 4 on cognitive decline.

Shadlen MF, Larson EB, Wang L, Phelan EA, McCormick WC, Jolley L, Teri L, van Belle G. Shadlen MF, et al. Neurobiol Aging. 2005 Jan;26(1):17-24. doi: 10.1016/j.neurobiolaging.2004.03.005. Neurobiol Aging. 2005. PMID: 15585342

6

What's new in Alzheimer's disease treatment? Reasons for optimism about future pharmacologic options.

Shadlen MF, Larson EB. Shadlen MF, et al. Postgrad Med. 1999 Jan;105(1):109-18. doi: 10.3810/pgm.1999.01.500. Postgrad Med. 1999. PMID: 9924498 Review.

7

The epidemiology of Alzheimer's disease and vascular dementia in Japanese and African-American populations: the search for etiological clues.

Shadlen MF, Larson EB, Yukawa M. Shadlen MF, et al. Neurobiol Aging. 2000 Mar-Apr;21(2):171-81. doi: 10.1016/s0197-4580(00)00115-9. Neurobiol Aging. 2000. PMID: 10867202 Review. No abstract available.

8

Education, cognitive test scores, and black-white differences in dementia risk.

Shadlen MF, Siscovick D, Fitzpatrick AL, Dulberg C, Kuller LH, Jackson S. Shadlen MF, et al. J Am Geriatr Soc. 2006 Jun;54(6):898-905. doi: 10.1111/j.1532-5415.2006.00747.x. J Am Geriatr Soc. 2006. PMID: 16776783

9

Effects of age and ethnicity on the link between APOE epsilon4 and Alzheimer disease.

Shadlen MF. Shadlen MF. JAMA. 1998 Feb 25;279(8):581; author reply 581-2. JAMA. 1998. PMID: 9486747 No abstract available.

10

Misuse of durable power of attorney for health care.

Goldstein MK, Shadlen MF. Goldstein MK, et al. Among authors: shadlen mf. J Am Geriatr Soc. 1991 Jul;39(7):730. doi: 10.1111/j.1532-5415.1991.tb03632.x. J Am Geriatr Soc. 1991. PMID: 2061542 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters